Impacts of serum phosphate on mortality in hospitalized patients and patients with chronic kidney disease in a general hospital
Xuemei GENG,Yimei WANG,Xiaoyan ZHANG,Xialian XU,Jing LIN,Jiachang HU,Ping JIA,Yeqing XIE,Jiawei YU,Jie TENG,Xiaoqiang DING
2017-01-01
Abstract:Objective To explore the relationship between serum phosphate concentration and mortality in hospitalized patients and patients with chronic kidney disease (CKD) in a general hospital.Methods All admissions to Zhongshan Hospital,Fudan University from October 1,2014 to September 30,2015 were screened.Serum phosphate level and relevant clinical data including age,sex,height,weight,comorbidities,blood routine,urine routine,hepatic-renal function,electrolytes,fast blood glucose,hospital deaths and death causes were extracted from the electronic database.All admissions were divided into six groups by admission phosphate levels asfollows:0.46 mmol/L or less,0.47 to 0.79 mmol/L,0.80 to 1.12 mmol/L,1.13 to 1.45 mmol/L,1.46 to 1.78 mmol/L,and 1.79 mmol/L or higher.A multivariable logistic regression model was applied to assess the association between serum phosphate level and in-hospital mortality in hospitalized patients and CKD patients.Results A total of 57 786 patients were included in this study.The overall mortality was 1.2％ (678 patients).Hypophosphatemia (serum phosphate level was less than 0.80 mmol/L) was found in 6.5％ of all patients and hyperphosphatemia (serum phosphate level was higher than 1.45 mmol/L) was noted in 6.6％ of all patients.The mortality in patients with hypophosphatemia and hyperphosphatemia was significantly higher than that in patients with normal serum phosphate (P ＜ 0.001).The top three departments of hypophosphatemia were surgery department of liver neoplasms (25.3％),internal medicine department of liver neoplasms (14.3％) and department of gastroenterology (10.4 ％).The top three departments of hyperphosphatemia were department of nephrology (34.6％),department of endocrinology (13.6％) and department of hematology (13.5％).Distribution of phosphate levels was as follows:0.46 mmol/L or less in 367 patients (0.63％),0.47 to 0.79 mmol/L in 3 408 patients (5.90％),0.80 to 1.12 mmol/L in 25 256 patients (43.71％),1.13 to 1.45 mmol/L in 24 942 patients (43.16％),1.46 to 1.78 mmol/L in 3 009 patients (5.21％),1.79 mmol/L or higher in 804 patients (1.39％).The mortality rates of each group were 7.63％,3.17％,1.05％,0.69％,1.23％ and 8.33％,respectively.The lowest in-hospital mortality (0.69％) occurred in patients with phosphate levels between 1.13 and 1.45 mmol/L,which was defined as a reference group.Adjusting for age,sex,systolic blood pressure,diastolic blood pressure,fasting blood glucose,albumin,hemoglobin,white blood cells,estimated glomerular filtration rate (eGFR),admission electrolytes (including serum sodium,potassium,chlorine,calcium,magnesium)and comorbidities (including hypertension,diabetes mellitus,coronary disease,malignancy,stroke,liver cirrhosis,heart failure,CKD and acute kidney injury),it was revealed that,compared with the reference group,there were higher death risks in the patients with phosphate level of 0.46 mmol/L or less (OR =3.071,95％ CI 1.797-5.247),0.47 to 0.79 mmol/L (OR =1.900,95％ CI 1.410-2.561),0.80 to 1.12 mmol/L (OR=1.319,95％ CI 1.056-1.648) and 1.79 mmol/L or higher (OR =2.292,95％ CI 1.470-3.574);while the phosphate level of 1.46 to 1.78 mmol/L was not independently associated with in-hospital mortality in hospitalized patients (OR =1.144,95％ CI 0.755-1.736).There were 11 392 patients with CKD.They were divided into six groups by the same distribution of phosphate levels in all the hospitalized patients,and the mortality rates of each group were 13.68％,6.80％,2.47％,1.84％,2.84％ and 9.16％,respectively.The lowest in-hospital mortality (1.84％) occurred in the patients with phosphate level of 1.13 to 1.45 mmol/L which was defined as a reference group.Adjusting for the same factors above,the death risk in the groups of the phosphate level of 0.46 mmol/L or less (OR =2.739,95％ CI 1.203-6.235),0.47 to 0.79 mmol/L (OR =1.794,95％CI 1.146-2.808),0.80 to 1.12 mmol/L (OR=1.539,95％CI 1.093-2.168) and 1.79 mmol/L or higher (OR=2.759,95％ CI 1.673-4.548) were significantly higher than that in the reference group,but aphosphate level of 1.46 to 1.78 mmol/L was not independently associated with in-hospital mortality in CKD patients (OR =1.247,95％ CI 0.726-2.141).Conclusion Abnormal serum phosphate is common in hospitalized patients.Hypophosphatemia and severe hyperphosphatemia are independent risk factors of death in hospitalized patients and CKD patients.